+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atracurium Market by Application, End Users, Dosage Forms, Distribution Channels, Patient Population - Global Forecast 2025-2030- Product Image
Atracurium Market by Application, End Users, Dosage Forms, Distribution Channels, Patient Population - Global Forecast 2025-2030- Product Image
Sale

Atracurium Market by Application, End Users, Dosage Forms, Distribution Channels, Patient Population - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6013935
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Atracurium Market grew from USD 234.84 million in 2023 to USD 242.31 million in 2024. It is expected to continue growing at a CAGR of 3.69%, reaching USD 302.78 million by 2030.

Atracurium, a non-depolarizing skeletal muscle relaxant primarily used during anesthesia to facilitate tracheal intubation and provide skeletal muscle relaxation, operates in a niche but crucial segment of the pharmaceuticals market. The necessity of atracurium arises from its ability to safely and effectively induce muscle relaxation during surgeries, intensive care treatments, and mechanical ventilation processes. With applications predominantly in surgical suites and critical care settings, the end-use scope is largely linked to healthcare institutions such as hospitals and surgical centers. Market growth is underpinned by the rising number of surgical procedures globally, increasing geriatric population, and expanding access to healthcare services in developing nations. However, growth can be challenged by factors such as the potential for generic competition, regulatory hurdles, and the need for skilled professionals to administer and monitor patient responses. Furthermore, market volatility linked to raw material supply chains and stringent pharmaceutical regulations can pose significant limitations.

Latest potential opportunities in this market can be captured through enhanced research into improved formulations and the development of adjunct therapies that can synergize with atracurium to enhance patient recovery rates or reduce side effects. Innovation in administration techniques, such as the exploration of alternative delivery systems or dosing regimes, also presents future potential. Pharmaceutical companies could benefit from collaborations with healthcare technology firms to develop integrated systems for monitoring neuromuscular function. Understanding the growing demand for minimally invasive surgical procedures, fostering partnerships with emerging markets to tap into untapped potential, and navigating intellectual property landscapes effectively are crucial strategic steps. A customer-centric approach focusing on patient safety, efficacy, and optimizing the peri-operative experience can drive competitive advantage. Overall, robust R&D investment into next-generation muscle relaxants, outreach within emerging markets, and strategic adaptation to evolving healthcare delivery models represent vital paths for sustaining business growth in the atracurium market.

Understanding Market Dynamics in the Atracurium Market

The Atracurium Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing adoption of Atracurium in critical care settings for mechanical ventilation
    • Increasing awareness among healthcare professionals about the benefits of Atracurium usage
    • Technological innovations in medical devices enhancing the effectiveness of neuromuscular blockers
    • Accelerating investments in healthcare infrastructure in emerging economies
  • Market Restraints
    • The rising prevalence of drug shortages influences the atracurium supply chain
    • Stringent regulatory compliances and approval processes hamper atracurium market expansion
  • Market Opportunities
    • Rising incidences of chronic diseases necessitating surgeries and thus increasing Atracurium usage
    • Expansion of surgical centers and hospitals boosting the Atracurium market
    • Government regulations and policies supporting the use of Atracurium in medical procedures
  • Market Challenges
    • Challenges in maintaining the quality and safety standards of atracurium during production and distribution
    • Regulatory hurdles and compliance issues affecting the atracurium market growth and expansion

Exploring Porter’s Five Forces for the Atracurium Market

Porter’s Five Forces framework further strengthens the insights of the Atracurium Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Atracurium Market

External macro-environmental factors deeply influence the performance of the Atracurium Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Atracurium Market

The Atracurium Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Atracurium Market

The Atracurium Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Atracurium Market

The Atracurium Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Atracurium Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare, Inc., Alembic Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Aurobindo Pharma Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Eurolife Healthcare Pvt. Ltd., Fresenius Kabi USA, LLC, Hikma Pharmaceuticals PLC, Kyowa Kirin Co., Ltd., Lupin Limited, Mylan N.V., Novartis AG, Pfizer Inc., Sagent Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., X-GEN Pharmaceuticals, and Zydus Cadila.

Market Segmentation & Coverage

This research report categorizes the Atracurium Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Application
    • Emergency Departments
    • Intensive Care Units
      • Adult Intensive Care Units
      • Pediatric Intensive Care Units
    • Surgical Procedures
      • Cardiac Surgery
      • General Surgery
      • Neurosurgery
      • Orthopedic Surgery
  • End Users
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
      • Private Hospitals
      • Public Hospitals
  • Dosage Forms
    • Injection
    • Intravenous
  • Distribution Channels
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Patient Population
    • Adult Patients
    • Pediatric Patients
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of Atracurium in critical care settings for mechanical ventilation
5.1.1.2. Increasing awareness among healthcare professionals about the benefits of Atracurium usage
5.1.1.3. Technological innovations in medical devices enhancing the effectiveness of neuromuscular blockers
5.1.1.4. Accelerating investments in healthcare infrastructure in emerging economies
5.1.2. Restraints
5.1.2.1. The rising prevalence of drug shortages influences the atracurium supply chain
5.1.2.2. Stringent regulatory compliances and approval processes hamper atracurium market expansion
5.1.3. Opportunities
5.1.3.1. Rising incidences of chronic diseases necessitating surgeries and thus increasing Atracurium usage
5.1.3.2. Expansion of surgical centers and hospitals boosting the Atracurium market
5.1.3.3. Government regulations and policies supporting the use of Atracurium in medical procedures
5.1.4. Challenges
5.1.4.1. Challenges in maintaining the quality and safety standards of atracurium during production and distribution
5.1.4.2. Regulatory hurdles and compliance issues affecting the atracurium market growth and expansion
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Atracurium Market, by Application
6.1. Introduction
6.2. Emergency Departments
6.3. Intensive Care Units
6.3.1. Adult Intensive Care Units
6.3.2. Pediatric Intensive Care Units
6.4. Surgical Procedures
6.4.1. Cardiac Surgery
6.4.2. General Surgery
6.4.3. Neurosurgery
6.4.4. Orthopedic Surgery
7. Atracurium Market, by End Users
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Clinics
7.4. Hospitals
7.4.1. Private Hospitals
7.4.2. Public Hospitals
8. Atracurium Market, by Dosage Forms
8.1. Introduction
8.2. Injection
8.3. Intravenous
9. Atracurium Market, by Distribution Channels
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Atracurium Market, by Patient Population
10.1. Introduction
10.2. Adult Patients
10.3. Pediatric Patients
11. Americas Atracurium Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Atracurium Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Atracurium Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ATRACURIUM MARKET RESEARCH PROCESS
FIGURE 2. ATRACURIUM MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ATRACURIUM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ATRACURIUM MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ATRACURIUM MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ATRACURIUM MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. ATRACURIUM MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ATRACURIUM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ATRACURIUM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ATRACURIUM MARKET DYNAMICS
TABLE 7. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ATRACURIUM MARKET SIZE, BY EMERGENCY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ATRACURIUM MARKET SIZE, BY ADULT INTENSIVE CARE UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ATRACURIUM MARKET SIZE, BY PEDIATRIC INTENSIVE CARE UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ATRACURIUM MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ATRACURIUM MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ATRACURIUM MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 63. CANADA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 64. CANADA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 65. CANADA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 66. CANADA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 67. CANADA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 68. CANADA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 103. CHINA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CHINA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 105. CHINA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 106. CHINA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 107. CHINA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 108. CHINA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 109. CHINA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 110. CHINA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 111. INDIA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. INDIA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 113. INDIA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 114. INDIA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 115. INDIA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 116. INDIA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 117. INDIA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 118. INDIA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 127. JAPAN ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. JAPAN ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 129. JAPAN ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 130. JAPAN ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 131. JAPAN ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. JAPAN ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 133. JAPAN ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 134. JAPAN ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 167. TAIWAN ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. TAIWAN ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 169. TAIWAN ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 175. THAILAND ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. THAILAND ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 177. THAILAND ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 178. THAILAND ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 179. THAILAND ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 180. THAILAND ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 181. THAILAND ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 182. THAILAND ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 183. VIETNAM ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. VIETNAM ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 200. DENMARK ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. DENMARK ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 202. DENMARK ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 203. DENMARK ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 204. DENMARK ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 206. DENMARK ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 208. EGYPT ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. EGYPT ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 210. EGYPT ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 211. EGYPT ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 212. EGYPT ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 213. EGYPT ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 214. EGYPT ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 215. EGYPT ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 216. FINLAND ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. FINLAND ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 218. FINLAND ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 219. FINLAND ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 220. FINLAND ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 224. FRANCE ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. FRANCE ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 226. FRANCE ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 227. FRANCE ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 228. FRANCE ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. FRANCE ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 230. FRANCE ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 231. FRANCE ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 232. GERMANY ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. GERMANY ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 234. GERMANY ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 235. GERMANY ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 236. GERMANY ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 237. GERMANY ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 238. GERMANY ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 239. GERMANY ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 248. ITALY ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. ITALY ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 250. ITALY ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 251. ITALY ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 252. ITALY ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 253. ITALY ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 254. ITALY ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 255. ITALY ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 272. NORWAY ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. NORWAY ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 274. NORWAY ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 275. NORWAY ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 276. NORWAY ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 278. NORWAY ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 279. NORWAY ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 280. POLAND ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. POLAND ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 282. POLAND ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 283. POLAND ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 284. POLAND ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 285. POLAND ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 286. POLAND ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 287. POLAND ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 288. QATAR ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. QATAR ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 290. QATAR ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 291. QATAR ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 292. QATAR ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 293. QATAR ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 294. QATAR ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 295. QATAR ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 320. SPAIN ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. SPAIN ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 322. SPAIN ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 323. SPAIN ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 324. SPAIN ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 325. SPAIN ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 326. SPAIN ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 327. SPAIN ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 336. SWITZERLAND ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. SWITZERLAND ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 338. SWITZERLAND ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 339. SWITZERLAND ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 340. SWITZERLAND ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 344. TURKEY ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. TURKEY ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 346. TURKEY ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 347. TURKEY ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 348. TURKEY ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 349. TURKEY ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 350. TURKEY ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 351. TURKEY ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 360. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 361. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY INTENSIVE CARE UNITS, 2018-2030 (USD MILLION)
TABLE 362. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 363. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 364. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 365. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 366. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 367. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY PATIENT POPULATION, 2018-2030 (USD MILLION)
TABLE 368. ATRACURIUM MARKET SHARE, BY KEY PLAYER, 2023
TABLE 369. ATRACURIUM MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Atracurium market, which are profiled in this report, include:
  • Accord Healthcare, Inc.
  • Alembic Pharmaceuticals Limited
  • Aspen Pharmacare Holdings Limited
  • Aurobindo Pharma Ltd.
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Emcure Pharmaceuticals Ltd.
  • Eurolife Healthcare Pvt. Ltd.
  • Fresenius Kabi USA, LLC
  • Hikma Pharmaceuticals PLC
  • Kyowa Kirin Co., Ltd.
  • Lupin Limited
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sagent Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • X-GEN Pharmaceuticals
  • Zydus Cadila

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 242.31 Million
Forecasted Market Value ( USD ) by 2030 $ 302.78 Million
Compound Annual Growth Rate3.6%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Atracurium besylate (CAS 64228-81-5) Global Market Research Report 2024 - Product Image

Atracurium besylate (CAS 64228-81-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Pregabalin Market by Dosage Forms, Drug Class, Application, End-Users, Distribution Channel - Global Forecast 2025-2030 - Product Image

Pregabalin Market by Dosage Forms, Drug Class, Application, End-Users, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Ankylosing Spondylitis Market by Drug, Type of Molecule, Mechanism Of Action, Route Of Administration, Dosage Forms, End User - Global Forecast 2025-2030 - Product Image

Ankylosing Spondylitis Market by Drug, Type of Molecule, Mechanism Of Action, Route Of Administration, Dosage Forms, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Oral Solid Dosage Forms (OSDF) and Pharma Excipients - Global Strategic Business Report - Product Image

Oral Solid Dosage Forms (OSDF) and Pharma Excipients - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Fibrin Sealants Market By Dosage Forms, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Fibrin Sealants Market By Dosage Forms, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 283 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.